Virginia Retirement Systems Et Al Atara Biotherapeutics, Inc. Transaction History

Virginia Retirement Systems Et Al

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$8.44 - $16.89 $106,344 - $212,814	-12,600 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$14.7 - $19.89 $58,800 - $79,560	-4,000 Reduced 24.1%	12,600 $199,000
Q3 2021 Oct 21, 2021	BUY	$11.99 - $17.9 $7,194 - $10,740	600 Added 3.75%	16,600 $297,000
Q2 2021 Aug 13, 2021	BUY	$12.89 - $16.58 $206,240 - $265,280	16,000 New	16,000 $249,000

3.07M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $763M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.